RIQAS Maternal Screening EQA Program
RIQAS (Randox International Quality Assessment Scheme) is the world’s largest global EQA scheme serving over 24,000 laboratory participants in more than 105 countries worldwide.
Combining all six parameters tested during first and second trimester screening including Papp-A and Inhibin A the RIQAS maternal screening programme is designed to help laboratories reduce the number of individual programmes required whilst also reducing costs.
RIQAS Maternal Screening EQA Program Features:
- Accredited to ISO/IEC 17043:2010
- 100% human serum samples
- Monthly sampling
- User friendly reports available within 72 hours
- End-of cycle reports and certificates of participation provided
- Register up to five instruments at no extra cost
Analytes: AFP, hCG (Beta), hCG (Total), Inhibin-A, PAPP-A, Unconjugated Oestriol.